Omnicare LLC & CVS Reach $440M FCA Settlement

National Law Review
Omnicare and CVS agreed to a $440 million settlement with the DOJ over false Medicare/Medicaid claims for prescriptions lacking valid orders.

Summary

Omnicare LLC and its parent CVS Health Corporation have reached a proposed $440 million settlement with the Department of Justice to resolve allegations that Omnicare dispensed prescription medications to long‑term care residents without valid prescriptions. The settlement follows a nearly $949 million False Claims Act judgment previously entered against the company, which Omnicare is seeking to reduce through bankruptcy proceedings, with a final hearing set for August 12, 2026. The case originated from a 2015 qui tam complaint filed by pharmacist Uri Bassan, alleging false Medicare and Medicaid claims; after government intervention, Bassan is entitled to 15‑25 percent of the recovery, potentially around $88 million at the midpoint of that range.

(Source:National Law Review)

New York Post

Costco class action lawsuit settlement could earn affected customers $500

The Philadelphia Inquirer

A property manager used rent price-setting algorithms that were banned in Philly last year, lawsuit says

Bloomberg Tax News

Union Sues EEOC Over Suspended Federal Worker Class Actions (1)

The Economic Times

How Oracle's 2012 court defeat became the heart of £270 million lawsuit against Microsoft

7NEWS Australia

Johnson & Johnson to pay $7.9 billion in landmark talc cancer settlement as Australian class action gathers pace

Natural News

Federal Judge Approves $1.5 Billion Copyright Settlement Against AI Company Anthropic

San Diego Union-Tribune

San Diego appeals court finds that license plate data collection alone is not harm

Charleston Post and Courier

Richland County to settle class-action case over inadequate care brought by mentally ill detainees

City A.M.

Trawlerman can overhaul Scandinavia for Goodwood gold

Electrek

Tesla partly settles racism lawsuit as hundreds of workers press on

Mint

UPI-linked PF claim settlement facility rollout delayed: Expected launch timeline and key benefits for EPFO members

Bnn Bloomberg

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

CP24 Toronto

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

The Globe and Mail

Deadline nears to file claim in class-action lawsuit over drug Rexulti

BayToday

Deadline fast approaching for Canadians to file claim in class-action drug suit